耻骨下闭孔神经阻滞减少髋关节镜术后阿片类药物消耗:三盲随机安慰剂对照试验
该三盲随机对照试验纳入40例日间髋关节镜手术患者,术前分别接受耻骨下闭孔神经阻滞(15 ml 5 mg/mL布比卡因加5 μg/mL肾上腺素)或安慰剂。主要结局为麻醉后监护室前3小时阿片类药物消耗量,34例患者分析显示阻滞组平均静脉吗啡当量11.9 mg,安慰剂组19.7 mg(p<0.001),且阻滞组髋内收肌力显著降低,其他次要结局无组间差异。
要点
- 耻骨下闭孔神经阻滞可减少髋关节镜术后前3小时静脉吗啡当量消耗约40%。
- 阻滞组髋内收肌力显著降低,需关注术后肌力评估。
- 疼痛和恶心等次要结局未见组间差异。
核心结论
- 耻骨下闭孔神经阻滞显著减少髋关节镜术后前3小时阿片类药物消耗,静脉吗啡当量降低40%。
研究设计与样本
- 三盲、随机、安慰剂对照试验,纳入40例日间髋关节镜手术患者,术前接受主动或安慰剂耻骨下闭孔神经阻滞,34例纳入主要结局分析。
主要发现
- 阻滞组平均静脉吗啡当量消耗11.9 mg,安慰剂组19.7 mg(p<0.001)。
- 阻滞组髋内收肌力显著降低。
- 疼痛、恶心等其他次要结局无组间差异。
关键数值与推荐
- 主动阻滞使用15 ml布比卡因5 mg/mL加肾上腺素5 μg/mL。
- 主要结局为麻醉后监护室前3小时阿片类药物消耗量。
临床怎么用
- 对髋关节镜手术患者可考虑术前实施耻骨下闭孔神经阻滞以减少术后早期阿片类药物需求,但需注意髋内收肌力减弱的可能。
局限性
- 样本量较小,40例入组、34例分析主要结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip arthroscopy causes severe pain during the first few hours in the postoperative care unit. This is probably due to the intraoperative stretching of the hip joint capsule. Pain relief requires high doses of opioids which may prolong recovery and may cause opioid-related adverse events.The majority of hip joint capsule nociceptors are located anteriorly. The obturator nerve innervates the anteromedial part of the hip joint capsule. We hypothesized that a subpectineal obturator nerve block using 15 ml bupivacaine 5 mg/mL with added epinephrine 5 μg/mL would reduce the opioid consumption after hip arthroscopy. METHODS: 40 ambulatory hip arthroscopy patients were enrolled in this randomized, triple-blind controlled trial. All patients were allocated to a preoperative active or placebo subpectineal obturator nerve block. The primary outcome was opioid consumption for the first 3 hours in the postanesthesia care unit. Secondary outcomes were pain, nausea, and hip adductor strength. RESULTS: 34 patients were analyzed for the primary outcome. The mean intravenous morphine equivalent consumption in the subpectineal obturator nerve block group was 11.9 mg vs 19.7 mg in the placebo group (p<0.001). The hip adductor strength was significantly reduced in the active group. No other intergroup differences were observed regarding the secondary outcomes. CONCLUSION: We found a significant reduction in the opioid consumption for patients receiving an active subpectineal obturator nerve block. The postoperative intravenous morphine equivalent reduction the first painful 3 hours was reduced by 40% for patients receiving a subpectineal obturator nerve block in this randomized, triple-blind trial. TRIAL REGISTRATION NUMBER: EudraCT database 2021-006575-42.
引用
- Jessen C, Espelund US, Brix LD, et al. Subpectineal obturator nerve block reduces opioid consumption after hip arthroscopy: a triple-blind, randomized, placebo-controlled trial. Reg Anesth Pain Med. 2025. PMID: 38925710. doi:10.1136/rapm-2024-105638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。